News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
145,546 Results
Type
Article (5601)
Company Profile (41)
Press Release (139902)
Section
Business (49645)
Career Advice (131)
Deals (8341)
Drug Delivery (13)
Drug Development (17816)
Employer Resources (20)
FDA (3080)
Job Trends (3646)
News (76805)
Policy (5667)
Tag
2027 Genetown Standard (1)
Academia (413)
Accelerated approval (14)
ADA (7)
Adcomms (1)
Allergies (40)
Alliances (6078)
ALS (31)
Alzheimer's disease (473)
Antibody-drug conjugate (ADC) (124)
Approvals (3294)
Artificial intelligence (87)
ASCO (106)
Autoimmune disease (81)
Automation (9)
Bankruptcy (53)
Best Places to Work (3335)
BIO (5)
BIOSECURE Act (1)
Biosimilars (45)
Biotechnology (33)
Bladder cancer (80)
Brain cancer (10)
Breast cancer (221)
Cancer (1510)
Cardiovascular disease (116)
Career advice (118)
Career pathing (2)
CAR-T (50)
CDC (5)
Celiac Disease (1)
Cell therapy (150)
Cervical cancer (12)
Clinical research (16244)
Collaboration (257)
Company closure (1)
Compensation (164)
Complete response letters (12)
COVID-19 (515)
CRISPR (16)
C-suite (116)
Cystic fibrosis (37)
Data (2334)
Depression (35)
Dermatology (36)
Diabetes (156)
Diagnostics (1587)
Digital health (16)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (52)
Drug pricing (22)
Drug shortages (2)
Duchenne muscular dystrophy (94)
Earnings (40126)
Editorial (8)
Employer branding (6)
Employer resources (15)
Events (23336)
Executive appointments (89)
FDA (4088)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (245)
Gene editing (33)
Generative AI (5)
Gene therapy (105)
GLP-1 (279)
Government (809)
Grass and pollen (2)
Guidances (312)
Healthcare (4720)
Hematology (59)
HIV (28)
Huntington's disease (16)
IgA nephropathy (29)
Immunology and inflammation (60)
Immuno-oncology (27)
Indications (67)
Infectious disease (581)
Inflammatory bowel disease (48)
Inflation Reduction Act (3)
Influenza (31)
Intellectual property (50)
Interviews (12)
IPO (5435)
IRA (5)
Job creations (428)
Job search strategy (106)
JPM (40)
Kidney cancer (11)
Labor market (34)
Layoffs (130)
Leadership (5)
Legal (1057)
Liver cancer (26)
Longevity (3)
Lung cancer (228)
Lymphoma (159)
Machine learning (6)
Management (6)
Manufacturing (139)
Marketing (1)
MASH (76)
Medical device (3429)
Medtech (3473)
Mergers & acquisitions (3170)
Metabolic disorders (425)
mRNA (60)
Multiple sclerosis (62)
NASH (4)
Neurodegenerative disease (81)
Neuropsychiatric disorders (27)
Neuroscience (817)
Neurotech (1)
NextGen: Class of 2026 (1070)
Non-profit (837)
Now hiring (2)
Obesity (179)
Opinion (28)
Ovarian cancer (49)
Pain (43)
Pancreatic cancer (65)
Parkinson's disease (68)
Partnered (2)
Patents (101)
Patient recruitment (99)
Peanut (19)
People (6810)
Pharmaceutical (6)
Pharmacy benefit managers (3)
Phase 1 (4277)
Phase 2 (6901)
Phase 3 (6489)
Pipeline (3743)
Policy (23)
Postmarket research (558)
Preclinical (1485)
Press Release (12)
Prostate cancer (73)
Psychedelics (8)
Radiopharmaceuticals (68)
Rare diseases (240)
Real estate (647)
Recruiting (9)
Regulatory (4897)
Reports (19)
Research institute (405)
Resumes & cover letters (17)
Rett syndrome (14)
RNA editing (5)
RSV (18)
Schizophrenia (60)
Series A (23)
Series B (21)
Service/supplier (3)
Sickle cell disease (21)
Special edition (13)
Spinal muscular atrophy (42)
Sponsored (4)
Startups (391)
Stomach cancer (6)
Supply chain (16)
Tariffs (9)
The Weekly (4)
Vaccines (219)
Venture capital (25)
Weight loss (124)
Women's health (24)
Worklife (1)
Date
Last 7 days (113)
Last 30 days (428)
Last 365 days (7711)
2026 (4256)
2025 (7033)
2024 (7848)
2023 (12425)
2022 (25887)
2021 (10841)
2020 (9929)
2019 (8582)
2018 (6335)
2017 (5599)
2016 (5005)
2015 (6450)
2014 (4392)
2013 (3098)
2012 (3475)
2011 (3626)
2010 (3374)
Location
Africa (97)
Alabama (16)
Arizona (49)
Arkansas (1)
Asia (8668)
Australia (1292)
California (3331)
Canada (992)
China (332)
Colorado (172)
Connecticut (122)
Delaware (154)
Europe (20522)
Florida (426)
Georgia (90)
Hawaii (1)
Idaho (9)
Illinois (218)
India (20)
Indiana (171)
Iowa (8)
Japan (160)
Kansas (29)
Kentucky (10)
Louisiana (22)
Maine (31)
Maryland (374)
Massachusetts (2018)
Michigan (80)
Minnesota (164)
Mississippi (2)
Missouri (25)
Montana (8)
Nebraska (6)
Nevada (32)
New Hampshire (12)
New Jersey (1063)
New Mexico (3)
New York (908)
North Carolina (386)
North Dakota (1)
Northern California (1772)
Ohio (71)
Oklahoma (3)
Oregon (3)
Pennsylvania (772)
Puerto Rico (1)
Rhode Island (2)
South America (195)
South Carolina (5)
Southern California (1320)
Tennessee (41)
Texas (433)
United States (11318)
Utah (78)
Virginia (95)
Washington D.C. (6)
Washington State (246)
West Virginia (1)
Wisconsin (17)
145,546 Results for "26".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medincell Reports FY 2025-26 Annual Results
June 17, 2026
·
2 min read
Press Releases
Crescent Biopharma Announces Grants of Inducement Awards - June 26, 2026
June 28, 2026
·
1 min read
Press Releases
Stonegate Updates Coverage on Burcon Nutrascience Corporation (BU) 4Q26
June 26, 2026
·
1 min read
Press Releases
Zealand Pharma - Transactions related to share buy-back program (week 26, 2026)
June 29, 2026
·
3 min read
Press Releases
Visage Highlights One Platform AI-Optimized at SIIM26
June 9, 2026
·
5 min read
Cancer
All eyes on Revolution, bispecific antibodies and more at ASCO26
Partners Summit Therapeutics and Akeso are expected to steal the show at the American Society of Clinical Oncology’s annual conference with data from their potential Keytruda rival, alongside Revolution Medicine’s groundbreaking pancreatic cancer candidate and other assets that could reshape patient care.
May 26, 2026
·
6 min read
·
Brianna Abbott
Press Releases
Editas Medicine Announces Proposed Public Offering - May 26, 2026
May 26, 2026
·
4 min read
Press Releases
Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 1Q26
June 4, 2026
·
1 min read
Press Releases
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences - May 26, 2026
May 26, 2026
·
2 min read
Press Releases
Novo Nordisk A/S - share repurchase programme - May 26, 2026
May 26, 2026
·
2 min read
1 of 14,555
Next
